The Mammalian Target of Rapamycin (mTOR) pathway is a downstream signaling pathway that can be regulated by the AKT, and was widely studied in the field of cancer for issues such as tumorigenesis, metastasis, and therapy (Saxton and Sabatini, 2017; Mossmann et al., 2018). The gene discussed is MTOR; the disease is cancer.